Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: A multicenter prospective study

Journal of Hepatology

Volumn 62, Issue 5, 2015, Pages 1056-1060

  Terg, Rubén ^a   Casciato, Paola ^b   Garbe, Cecilia ^c   Cartier, Mariano ^a   Stieben, Teodoro ^d   Mendizabal, Manuel ^e   Niveyro, Carla ^f   Benavides, Javier ^g   Marino, Mónica ^a   Colombato, Luis ^g   Berbara, Daniel ^d   Silva, Marcelo ^g   Salgado, Pablo ^a   Barreyro, Fernando ^g   Fassio, Eduardo ^c   Gadano, Adrian ^b  

^a HOSPITAL DE GASTROENTEROLOGÍA DR CARLOS BONORINO UDAONDO   (Argentina)

^b HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^c HOSPITAL NACIONAL PROFESOR ALEJANDRO POSADAS   (Argentina)

^d Hospital Madariaga   (Argentina)

^e UNIVERSIDAD AUSTRAL   (Argentina)

^f HOSPITAL SAN MARTÍN   (Argentina)

^g HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

Author keywords

Cirrhosis; Proton pump inhibitor; Spontaneous bacterial peritonitis

Indexed keywords

BILIRUBIN; PROTON PUMP INHIBITOR;

ACINETOBACTER; ADULT; ARTICLE; ASCITES; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL PERITONITIS; CELLULITIS; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FEMALE; HEPATORENAL SYNDROME; HUMAN; INCIDENCE; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; THROMBOCYTE COUNT; URINARY TRACT INFECTION; AGED; ARGENTINA; BACTERIAL INFECTIONS; CLINICAL TRIAL; COMPLICATION; DISEASE COURSE; HOSPITALIZATION; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PERITONITIS; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; STATISTICS; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; ARGENTINA; BACTERIAL INFECTIONS; DISEASE PROGRESSION; FEMALE; HOSPITALIZATION; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PERITONITIS; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; RISK ASSESSMENT; RISK FACTORS; STATISTICS AS TOPIC;

EID: 84927799218     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.11.036     Document Type: Article

References (26)

1. Pallarito K. How safe are popular reflux drugs? Experts debate evidence-linking acid-blockers to possible bone, heart problems. US News World Rep; 2009.
2. S. Gray, A. LaCroix, J. Larson, J. Robbins, J.A. Cauley, and J.E. Manson Proton pump inhibitor use, hip fracture and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative Arch Intern Med 170 2010 765 771
3. M. Asseri, T. Schroeder, J. Kramer, and R. Zackula Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile associated diarrhea in hospitalized patients Am J Gastroenterol 103 2008 2308 2313
4. R. Laheij, M. Sturkenboom, R. Hassing, B. Stricker, and J. Jansen Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs JAMA 292 2004 1955 1960
5. M. Campbell, K. Obstein, R. Reddy, and Y.X. Yang Association between proton pump inhibitors use and spontaneous bacterial peritonitis Dig Dis Sci 53 2008 394 398
6. J. Bajaj, Y. Zadvornova, D. Heuman, M. Hefeezullah, R. Hoffmann, and A. Sanyal Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic with ascites Am J Gastroenterol 104 2009 1130 1134
7. E.J. Choi, H.J. Lee, K.O. Kim, S.H. Lee, J.R. Eun, and B.I. Jang Association between acid suppressive therapy and spontaneous bacterial peritonitis in cirrhotic patients with ascites Scand J Gastroenterol 46 2011 616 620
8. G. Goel, A. Deshpande, R. Lopez, G. Hall, D. Van Duin, and W. Carey Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression Clin Gastroenterol Hepatol 10 2012 422 427
9. J. Bajaj, S. Ratliff, D. Heumann, and K. Lapane Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis Aliment Pharmacol Ther 36 2012 866 874
10. M. De Vos, B. de Vroey, B. García, C. Roy, J. Henrion, and P. Deltenre Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites Liver Int 33 2013 1316 1323
11. A. Deshpande, V. Pasupuleti, P. Thota, Ch. Pant, S. Mapara, and S. Hassan Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis J Gastroenterol Hepatol 28 2013 235 242
12. J.S. Bajaj, J.G. O'Laery, K.R. Reddy, F. Wong, J.C. Olson, and R.M. Subramanian Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American Consortium for the study of end-stage liver disease (NACSELD) experience Hepatology 6 2012 2328 2395
13. F.C. Morencos, G. de las Heras Castaño, L. Martin Ramos, M.J. Lopez Arias, F. Ledesma, and F. Pons Romero Small bowel bacterial overgrowth in patients with alcoholic cirrhosis Dig Dis Sci 40 1995 1252 1256
14. T.M. Bauer, B. Steinbrückner, F.E. Brinkmann, A.K. Ditzen, H. Schwacha, and J.J. Aponte Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis Am J Gastroenterol 96 2001 2962 2967
15. L. Lombardo, M. Foti, O. Ruggia, and A. Chiecchio Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy Clin Gastroenterol Hepatol 8 2010 504 508
16. J. Thorens, F. Froehlich, W. Schwizer, E. Saraga, J. Bille, and K. Gyr Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study Gut 39 1996 54 59
17. S. Hutchinson, and R. Logan The effect of long-term omeprazole on the glucose-hydrogen breath test in elderly patients Age Ageing 26 1997 87 89
18. D. Law, and M. Pimentel Proton pump inhibitor therapy does not affect hydrogen production on lactulose breath test in subjects with IBS Dig Dis Sci 55 2010 2302 2308
19. R.S. Choung, K.C. Ruff, A. Malhotra, L. Herrick, G.R. Locke 3rd, and W.S. Harmsen Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture Aliment Pharmacol Ther 33 2011 1059 1067
20. S.K. Ratuapli, T.G. Ellington, M.T. O'Neill, S.B. Umar, L.A. Harris, and A.E. Foxx-Orestein Proton pump inhibitors therapy use does not predispose to small intestinal bacterial overgrowth Am J Gastroenterol 107 2012 730 735
21. D. Compare, L. Pica, A. Rocco, F. De Giorgi, R. Cuomo, and G. Sarnelli Effects of long term PPI treatment on producing bowel symptoms and SIBO Eur J Clin Invest 41 2011 380 386
22. M. Fried, H. Siegrist, R. Frei, F. Froehlich, P. Duroux, and J. Thorens Duodenal bacterial overgrowth during treatment in outpatients with omeprazole Gut 35 1994 23 26
23. S. Lewis, S. Franco, G. Young, and S.J. O'Keefe Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole Aliment Pharmacol Ther 10 1966 1
24. S.P. Pereira, N. Gainsborough, and R.H. Dowling Drug induced hypochlorhydria causes high duodenal bacterial counts in the elderly Aliment Pharmacol Ther 12 1998 99 104
25. K. Zedwitz-Liebenstein, C. Wenisch, S. Patruta, B. Parschalk, F. Daxbock, and W. Graninger Omeprazole treatment diminished intra-and extracellular neutrophil reactive oxygen production and bactericidal activity Crit Care Med 30 2002 1118 1122
26. A. Goorhuis, M. Legaria, R. van den Berg, C. Harmanus, W. Klassen, and J. Brazier Application of multiple-locus variable-number tandem-repeat analysis to determine clonal spread of toxin A-negative Clostridium difficile in a general hospital in Buenos Aires, Argentina Clin Microbiol Infect 15 2009 1080 1086